Cargando…
Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC
In this paper we report long-term therapy management based on iterative de novo molecular and cellular analysis in a case of metastatic non-small cell lung cancer (NSCLC), with prior history of treated colorectal cancer. In the described case temporal tumor evolution, emergent therapy resistance and...
Autores principales: | Ranade, Anantbhushan, Patil, Darshana, Bhatt, Amit, Dhasare, Rucha, Datta, Vineet, Datar, Rajan, Akolkar, Dadasaheb |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789881/ https://www.ncbi.nlm.nih.gov/pubmed/31284461 http://dx.doi.org/10.3390/jpm9030034 |
Ejemplares similares
-
Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study
por: Patil, Darshana, et al.
Publicado: (2022) -
Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers
por: Crook, Timothy, et al.
Publicado: (2021) -
Evaluation of circulating tumor cell clusters for pan‐cancer noninvasive diagnostic triaging
por: Gaya, Andrew, et al.
Publicado: (2020) -
Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors
por: Crook, Timothy, et al.
Publicado: (2020) -
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
por: Crook, Timothy, et al.
Publicado: (2022)